close

Mergers and Acquisitions

1 2 3 33
Number of results: 648
Date Acquired company Acquiring company Amount Related
2022-04-11 Arranta Bio (USA-MA) Recipharm (Sweden) undisclosed manufacturing bioproduction
2022-04-11 Vibalogics (USA - MA) Recipharm (Sweden) undisclosed
2022-02-01 Genibet (Portugal) Recipharm (Sweden) undisclosed
2021-09-21 Comet Therapeutics (USA-MA) VectivBio (Switzerland) - Rare diseases
2021-07-21 Stelios Therapeutics (USA-CA) Lexeo Therapeutics (USA-NY) undisclosed Rare diseases - Cardiovascular diseases - gene therapy
2019-06-07 Nightstar Therapeutics (UK) Biogen (USA - MA) $800 million gene therapy - ophthalmological diseases
2018-12-03 TxCell (France) Sangamo Therapeutics (USA - CA) € 72 million Cell therapy - CAR-T - Immunological diseases
2018-10-18 Endocyte (USA - IN) Novartis (Switzerland) $ 2.1 billion Cancer - Oncology
2018-10-09 Vector Neurosciences (UK) MeiraGTx (USA - NY) Neurodegenerative diseases - CNS diseases
2018-10-01 Sanofi’s inhalation contract manufacturing business Recipharm (Sweden) undisclosed Technology - Services
2018-09-26 Syntimmune (USA - MA) Alexion Pharmaceuticals (USA -MA) up to $1.2 billion Autoimmune diseases
2018-09-20 Celenex Amicus Therapeutics (USA - NJ) $100 million in an upfront cash payment and up to $15 million in development milestones and $262 million in BLA/MAA submission and approval milestones Gene Therapy - Rare diseases - CNS diseases
2018-09-14 Bonti (USA - CA) Allergan (Ireland) $195 million and additional potential commercial milestone payments, subject to certain adjustments and other customary closing conditions aesthetic medicine
2018-09-13 Viratherapeutics (Austria) Boehringer Ingelheim (Germany) €210 million Cancer - Oncology
2018-09-06 Advanced Bioprocessing Business from BectonDickinson (USA - NJ) Thermo Fisher Scientific (USA - MA) Technology - Services
2018-08-31 Galderma R&D site in Sophia-Antipolis - Nestlé Skin Health (Switzerland) Nuvisan (Germany) CRO - analytical services
2018-07-19 Agilis Biotherapeutics (USA - MA) PTC Therapeutics (USA - NJ) up to $260 million and success-based milestones Rare diseases - CNS Diseases - Gene therapy  
2018-06-16 Interactive Biosoftware (Frane) Sophia Genetics (France - Switzerland) undisclosed
2018-05-15 Avexis (USA - IL) Novartis (Switzerland) $ 8.7 billion Gene therapy - Neurodegenerative diseases - CNS diseases
2018-05-14 AurKa Pharma (Canada) Eli Lilly (USA - IN) up to $575 million Cancer - Oncology